Lipocine Inc New (LPCN): Hedge Fund Ownership & Smart Money Signals (Q1 2026)

Q: Is it too late to buy Lipocine Inc New (LPCN) following the 2026 Q1 hedge fund 13F filings?

As of today, LPCN has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), LPCN gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Lipocine Inc New (LPCN)

44 + Investors. Track Smart Money conviction in LPCN. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — LPCN

Based on 44 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added LPCN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

44 hedge funds hold LPCN right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +132% more funds vs a year ago

fund count last 6Q

+25 new funds entered over the past year (+132% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 70% buying

31 buying13 selling

Last quarter: 31 funds were net buyers (22 opened a brand new position + 9 added to an existing one). Only 13 were sellers (9 trimmed + 4 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+13 vs last Q)

new funds entering per quarter

Funds opening a new LPCN position: 1 → 3 → 9 → 22. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

📌

Mixed — 25% long-term, 61% new

■ 25% conviction (2yr+) ■ 14% medium ■ 61% new

Of the 44 current holders: 11 (25%) held >2 years, 6 held 1–2 years, and 27 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

🚀

Acceleration phase — new buyers rushing in

2 → 1 → 3 → 9 → 22 new funds/Q

New funds entering each quarter: 1 → 3 → 9 → 22. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🌱

Early stage — 61% of holders entered in last year

■ 32% veterans ■ 7% 1-2yr ■ 61% new

Of 44 current holders: 27 (61%) entered in the past year, only 14 (32%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

📋

Smaller funds dominant — 7% AUM from top-100

7% from top-100 AUM funds

13 of 44 holders rank in the top 100 by AUM, but together hold only 7% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

6.2

out of 10

Moderate Exit Risk

Exit risk score 6.2/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	44	26	69.23%
13F Shares	3M	2M	91.19%
Total Value	$25M	$13M	90.23%
New Positions	22	9	+13
Increased Positions	9	6	+3
Closed Positions	4	4	-
Reduced Positions	9	2	+7
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

69.23%

13F Shares

91.19%

Total Value

$25M

$13M

90.23%

New Positions

+13

Increased Positions

Closed Positions

Reduced Positions

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q1)

44 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in LPCN. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 LPCN holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Squadron Capital Management LLC	1.32%	450,000	$3.6M
2	Rosalind Advisors, Inc.	0.71%	221,616	$1.8M
3	Birchview Capital, LP	0.51%	111,786	$893K
4	Ikarian Capital, LLC	0.33%	508,556	$4.1M
5	Seven Fleet Capital Management LP	0.32%	124,942	$998K
6	Mink Brook Asset Management LLC	0.30%	66,812	$534K
7	Exome Asset Management LLC	0.25%	60,861	$486K
8	Stempoint Capital LP	0.25%	160,420	$1.3M
9	AIGH Capital Management LLC	0.22%	200,000	$1.6M
10	Eversept Partners, LP	0.12%	294,989	$2.4M
11	Diadema Partners LP	0.07%	50,000	$400K
12	Persistent Asset Partners Ltd	0.04%	13,442	$107K
13	Boothbay Fund Management, LLC	0.01%	140,487	$1.1M
14	ADAR1 Capital Management, LLC	0.01%	23,180	$185K
15	J. Goldman & Co LP	0.01%	42,170	$337K
16	Prelude Capital Management, LLC	0.01%	12,630	$101K
17	XTX Topco Ltd	0.00%	17,923	$143K
18	Caldwell Sutter Capital, INC.	0.00%	471	$4K
19	PlanVest Financial, Inc	0.00%	111	—
20	Renaissance Technologies LLC	0.00%	38,497	$308K
21	Two Sigma Investments, LP	0.00%	33,750	$270K
22	Tower Research Capital LLC (TRC)	0.00%	933	$7K
23	Tidemark, LLC	0.00%	59	—
24	Vanguard Fiduciary Trust Co	0.00%	32,413	$259K
25	Vanguard Capital Management LLC	0.00%	200,668	$1.6M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Lipocine Inc New (LPCN)

What does the Smart Money Trend signal show for LPCN?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added LPCN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for LPCN?

More buyers than sellers — 70% buying: Last quarter: 31 funds were net buyers (22 opened a brand new position + 9 added to an existing one). Only 13 were sellers (9 trimmed + 4 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for LPCN holders?

Smaller funds dominant — 7% AUM from top-100: 13 of 44 holders rank in the top 100 by AUM, but together hold only 7% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held LPCN?

Mixed — 25% long-term, 61% new: Of the 44 current holders: 11 (25%) held >2 years, 6 held 1–2 years, and 27 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Lipocine Inc New (LPCN) following the 2026 Q1 hedge fund 13F filings?

As of today, LPCN has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), LPCN has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Lipocine Inc New (LPCN)

Smart Money Signals — LPCN

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +132% more funds vs a year ago

More buyers than sellers — 70% buying

More new buyers each quarter (+13 vs last Q)

Mixed — 25% long-term, 61% new

Acceleration phase — new buyers rushing in

Early stage — 61% of holders entered in last year

Smaller funds dominant — 7% AUM from top-100

Institutional Sentiment Summary — LPCN

Hedge Fund Ownership: LPCN

Market Analysis: LPCN

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: LPCN

Is It Too Late to Buy Lipocine Inc New (LPCN) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: LPCN

Statistics: LPCN

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — Lipocine Inc New (LPCN)

Welcome to 13Foresight!